Geron

Recent news

• Rating change
  Barclays Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $4
  Market Newswire · 2025/11/4
• Rating change
  A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $4 to $5
  Market Newswire · 2025/8/7
• Rating change
  Leerink Partners Maintains Geron(GERN.US) With Buy Rating, Announces Target Price $3
  Market Newswire · 2025/7/21
• Rating change
  Needham Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $4
  Market Newswire · 2025/11/6
• Rating change
  TD Cowen Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $3
  Market Newswire · 2026/1/29
• Company notice
  Geron | 4: Statement of changes in beneficial ownership of securities-Director O'Farrell Elizabeth G.
  SEC · 2026/5/27
• Company notice
  4: Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
  SEC · 2026/7/2
• Earnings Flash (GERN) Geron Corporation Reports Q2 Revenue $57.5M, Vs. FactSet Est of $55.3M
  MT Newswires · 2026/8/5
• Rating change
  TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $4
  Market Newswire · 2025/11/6
• Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $4
  Market Newswire · 2026/8/6
• TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $3
  Market Newswire · 2026/8/6
• Rating change
  A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $1 to $4
  Market Newswire · 2026/2/26
• H.C. Wainwright Maintains Geron(GERN.US) With Hold Rating
  Market Newswire · 2026/9/22
• Company notice
  Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
  SEC · 2026/10/2
• Rating change
  Goldman Sachs Maintains Geron(GERN.US) With Sell Rating, Maintains Target Price $1
  Market Newswire · 2026/2/26
• Rating change
  Scotiabank Maintains Geron(GERN.US) With Hold Rating, Maintains Target Price $1.5
  Market Newswire · 2025/8/7
• Company notice
  Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
  SEC · 2026/4/2
• Company notice
  Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
  SEC · 2026/5/27
• Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Geron (GERN)
  TipRanks · 2026/4/22
• Rating change
  TR | OpenAI - 4o Maintains Geron(GERN.US) With Hold Rating, Maintains Target Price $1.5
  Market Newswire · 2025/8/12

Headlines are aggregated automatically and are not independently verified or edited by our team.